|
Jul 1
|
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
|
|
Jun 30
|
Insider Stock Buying Reaches US$1.54m On Bausch + Lomb
|
|
Jun 30
|
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
|
|
Jun 26
|
Bausch + Lomb Closes Senior Secured Notes Offering, Refinancing And Upsizes US$2.32 Billion Term Loan Facility
|
|
Jun 26
|
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
|
|
Jun 25
|
The Top 5 Analyst Questions From Bausch + Lomb’s Q1 Earnings Call
|
|
Jun 23
|
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
|
|
Jun 18
|
Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering
|
|
Jun 18
|
Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering
|
|
Apr 7
|
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
|
|
Feb 14
|
Stocks to watch this week: Alibaba, Walmart, HSBC, Rio Tinto and Lloyds
|